BCL2 and lymphoma: In our current probe panel for lymphoma, we targeted the BCL2, BCL6, and MYC genes, bus also included the immunoglobulin loci IGH, IGK, IGL, and other loci implicated in hematolymphoid malignancies (Supplementary Data 1).